Ryner Lai, MBBS

All articles by Ryner Lai, MBBS

• Patient outcomes in MCL remain poor despite therapeutic advancements

  Outcomes among patients with mast cell leukemia remain relatively poor.

• What is hereditary alpha-tryptasemia, and how does it relate to SM? 

  18% of people with mastocytosis also have HαT.

• Study highlights the diagnostic challenges of SM-AMN

  A new study explores the diagnostic challenges posed by SM with an associated myeloid neoplasm (SM-AMN), an advanced form of SM.

• Research suggests midostaurin is still effective at lower doses in advanced SM

  Midostaurin is safe and effective in treating advanced systemic mastocytosis.

• What to know about systemic mastocytosis and antidepressants

  Depression is a mental health issue that should be taken seriously, as it can worsen over time if left untreated.

• Midostaurin can yield positive outcomes for patients with aggressive SM

  Midostaurin can be an effective therapy in the management of aggressive systemic mastocytosis.

• What to ask your doctor after being diagnosed with systemic mastocytosis

  From treatments to lifestyle changes, new patients will need answers to many aspects of living with SM.

• Shape of spinal fractures can help distinguish indolent SM from osteoporosis

  Vertebral fracture shape and distribution can be used to identify patients with a likely diagnosis of indolent SM.

• What you should know about experimental therapies for SM

  While experimental therapies offer hope for future treatments, patients should manage their expectations.

• When to seek a second opinion after a systemic mastocytosis diagnosis

  The risk of a misdiagnosis in SM is low.